Farmacología
Department
Karolinska Institute
Estocolmo, SueciaPublications in collaboration with researchers from Karolinska Institute (28)
2024
-
Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling
Science signaling, Vol. 17, Núm. 841, pp. eadi4747
2023
-
Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay
Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275
-
Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy
Autophagy, Vol. 19, Núm. 7, pp. 1952-1981
2022
-
Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures
Fluids and Barriers of the CNS, Vol. 19, Núm. 1
2021
-
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2017
2013
-
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism
Journal of Neuroscience, Vol. 33, Núm. 36, pp. 14331-14341
-
GABAergic circuits control spike-timing-dependent plasticity
Journal of Neuroscience, Vol. 33, Núm. 22, pp. 9353-9363
2012
-
The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons
PLoS Computational Biology, Vol. 8, Núm. 4
1999
-
Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine- lesioned rats
Neuroscience, Vol. 89, Núm. 3, pp. 781-797
1998
1997
-
125I-galanin binding sites in Alzheimer's disease: Increases in hippocampal subfields and a decrease in the caudate nucleus
Journal of Neurochemistry, Vol. 68, Núm. 3, pp. 1106-1113
-
Biological actions of endogenous excitatory amino acids and implications of their release under physiological and pharmacologically-induced conditions
Amino Acids
-
Modulation of catecholamine release by α2-adrenoceptors and I1-imidazoline receptors in rat brain
Brain Research, Vol. 744, Núm. 2, pp. 216-226
-
On the release of glutamate and aspartate in the basal ganglia of the rat: Interactions with monoamines and neuropeptides
Neuroscience and Biobehavioral Reviews, Vol. 21, Núm. 4, pp. 489-495
1996
-
Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: Modulation by the mesencephalic dopamine pathway via D1-subtype of receptor
Neuroscience, Vol. 74, Núm. 1, pp. 51-66
-
On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis
Journal of Neurochemistry, Vol. 66, Núm. 4, pp. 1726-1735
1995
-
In Vivo Modulation of Norepinephrine and Glutamate Release through Imidazoline Receptors in the Rat Central Nervous System
Annals of the New York Academy of Sciences, Vol. 763, Núm. 1, pp. 490-493
1994
-
CCK in Cerebral Cortex and at the Spinal Level
Annals of the New York Academy of Sciences, Vol. 713, Núm. 1, pp. 157-163